Inventor · disambiguated record
Philip Chamberlain
Also filed as: CHAMBERLAIN PHILIP · CHAMBERLAIN PHILIP P · Chamberlain Philip Paul
9 granted patents·4 pending applications·30 citations·filing 2007–2022
85Inventor score
Top patents by PatentIndex Score
13 records- 0188US10668057B2Compositions and methods for inducing conformational changes in cereblon and other E3 ubiquitin ligasesCELGENE CORP·Filed 2018·Granted Jun 2, 2020·3 cites·7 claims
- 0288US10428145B2PD-1 binding proteins and methods of use thereofCELGENE CORP·Filed 2016·Granted Oct 1, 2019·10 cites·155 claims
- 0388US10092555B2Compositions and methods for inducing conformational changes in cereblon and other E3 ubiquitin ligasesCELGENE CORP·Filed 2015·Granted Oct 9, 2018·8 cites·7 claims
- 0483US11419861B2Compositions and methods for inducing conformational changes in cereblon and other E3 ubiquitin ligasesCELGENE CORP·Filed 2020·Granted Aug 23, 2022·1 cites·7 claims
- 0580US10816544B2Methods for measuring small molecule affinity to cereblonCELGENE CORP·Filed 2018·Granted Oct 27, 2020·3 cites·7 claims
- 0679US11644461B2Methods for measuring small molecule affinity to cereblonCELGENE CORP·Filed 2020·Granted May 9, 2023·1 cites·6 claims
- 0779US11402372B2Methods for screening cereblon modifying compoundsCELGENE CORP·Filed 2019·Granted Aug 2, 2022·3 cites·2 claims
- 0878US10830762B2Compositions and methods for inducing conformational changes in cereblon and other E3 ubiquitin ligasesCELGENE CORP·Filed 2016·Granted Nov 10, 2020·1 cites·8 claims
- 0970US11733233B2Compositions and methods for inducing conformational changes in cereblon and other E3 ubiquitin ligasesCELGENE CORP·Filed 2020·Granted Aug 22, 2023·0 cites·17 claims
- 1070US2023272076A1PD-1 Binding Proteins and Methods of Use ThereofCELGENE CORP·Filed 2022·Application pending·0 cites
- 1161US2020255525A1Pd-1 binding proteins and methods of use thereofCELGENE CORP·Filed 2019·Application pending·0 cites
- 1257US2025052749A1Systems and methods of selecting compounds that induce conformational changes in mutant cereblonBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 1340US2009306039A1Compounds and compositions as itpkb inhibitorsPAN SHIFENG·Filed 2007·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →